medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2013, Number 4

<< Back Next >>

Acta Ortop Mex 2013; 27 (4)

Long-term results of the treatment of a giant cell tumor with en-bloc resection and unconventional hip arthroplasty with ipsilateral knee arthrodesis. Clinical case report and literature review

Rico-Martínez G, Linares-González LM, Delgado-Cedillo EA, Espejo-Sánchez G, Cerrada-Moreno LA, Clara-Altamirano MA

Language: Spanish
References: 22
Page: 250-255
PDF size: 284.03 Kb.


ABSTRACT

Giant cell tumor (GCT) is an aggressive benign neoplasia that accounts for 5% of primary bone tumors and 20% of all benign bone tumors. It appears almost exclusively after skeletal maturation, between 20 and 40 years of age, and is predominant among females. We report the case of a 39 year-old male patient who in 1988 sustained a left hip fracture in a pathological area. On July 20, 1988 he underwent excisional biopsy and curettage; on January 13, 1989 broad resection and arthrodesis of the left hip were performed with a cobra plate. The histopathologic diagnosis was GCT. On October 2, 1990 the cobra plate was removed due to fatigue. The patient was referred to our service with a floating hip joint and left knee anchylosis. On February 11, 1991 he underwent unconventional hip arthroplasty with a long stem up to the femoral supracondylar area. On February 2, 1995 the implant was removed due to fatigue. On February 16, 1995 an unconventional prosthesis with a long stem was re-implanted for knee arthrodesis. Final shortening was 10 cm. On November 17, 2010 he had radiographic signs of acetabular loosening and fatigue of the arthrodesis stem. On March 17, 2011 the unconventional prosthesis was removed, en-bloc resection of the distal femur was performed, and acetabular and femoral components were put in place. He is currently painless, walks with crutches and has 5.5 cm of shortening. The proximal femur is an infrequent site for GCT. Controlling the neoplasia and limb preservation are the major challenges that orthopedic surgeons and patients face. There are only a few published papers on revision of unconventional arthroplasty. There are no cases published on unconventional hip arthroplasty with ipsilateral knee arthrodesis.


REFERENCES

  1. Greenspan A, Wolfgang R: Tumores de huesos y articulaciones. Edit. Marban; 2002: 311-8.

  2. Canale T, Beaty JH: Campbell’s Operative orthopaedics. 11th Ed. Mosby, an imprint of Elsevier; 2007: 883-5.

  3. Thomas DM, Skubitz KM: Giant cell tumor of bone. Current Opinion in Oncology. 2009; 21: 338-44.

  4. Szendröi M: Giant cell tumour of bone. J Bone Joint Surg (Br). 2004; 86-B: 5-12.

  5. Mendenhall WM, et al: Giant cell tumor of bone. American Journal of Clinical Oncology. 2006; 29: 96-9.

  6. Stacy GS: Mimics on radiography of giant cell tumor of bone. AJR Am J Roentgenol. 2003; 181(6): 1583-9.

  7. Moreno Wright E y cols: Utilidad del metilmetacrilato en el tumor de células gigantes óseo. Acta Ortopédica Mexicana. 2003; 17(6): 281-6.

  8. Kapoor SK: Resection arthrodesis for giant cell tumors around the knee; Indian J Orthopedic. 2007; Apr;41(2):124-8.

  9. Nienke E: Revisions of extensive acetabular defects with impaction grafting and a cement cup; Clinical Orthopedic and Related Research. 2011; 469: 562-73.

  10. Lawless BM: Outcomes of isolated acetabular revision; Clin Orthop Relat Res. 2010; 468: 472-9.

  11. Kumta SM, Leung PC, Yip K, et al: Vascularized bone grafts in the treatment of juxta-articular giant-cell tumors of the bone. J Reconstr Microsurg. 1998; 14: 185-90.

  12. Catalán J, Calábria A, et al: Tumor de células gigantes óseo: aspectos clínicos e radiográficos de 115 casos. Radiol Bras. 2006; 39(2): 119-22.

  13. Sakayama K: Diagnostic and therapeutic problems of giant cell tumor in the proximal femur. Arch Orthop Trauma Surg. 2007; 127: 867-72.

  14. Kun T: Aggressive giant cell tumor at proximal femur after total hip arthroplasty. Chinese Medical Journal. 2008; 121(21): 2207-8.

  15. Khan SA, et al: Endoprosthetic replacement for giant cell tumour of the proximal femur. J Orthop Surg (Hong Kong). 2009; 17(3): 280-3.

  16. Zhongguo XF, et al: Treatment of tumorous disease in proximal femur by customized hip. Arthroplasty. 2006; 20(10): 989-91

  17. Rico MG y cols: Diseño de una prótesis no convencional bloqueada para cadera (RIMAG) a partir de mediciones de fémures mexicanos. Acta Ortop Mex. 2008; 22(2): 70-9.

  18. Ladero MF: Artroplastía de revisión de cadera con la prótesis tumoral PSO. Patología del Aparato Locomotor. 2005; 3(3): 168-72.

  19. Vidyadhara S: A novel approach to juxta-articular aggressive and recurrent giant cell tumours: resection arthrodesis using bone transport over an intramedullary nail. International Orthopaedics (SICOT). 2007; 31: 179-84.

  20. Yu X, Liu X, Fu Z: Reoperation after limb salvage surgery with prosthesis for bone tumor. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006; 20(10): 1011-3.

  21. Bryan D, et al: Why revision total hip arthroplasty fails. Clin Orthop Relat Res. 2009; 467: 166-73.

  22. Pasqualina L, et al: Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: A systematic review. J Can Chir. 2008; 51(6): 428-436.




2020     |     www.medigraphic.com